Global Tuberculosis Vaccines Market Insights and Forecast to 2026

Global Tuberculosis Vaccines Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Tuberculosis Vaccines Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccines Market Size Growth Rate by Type
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Vaccines Revenue 2015-2026
2.1.2 Global Tuberculosis Vaccines Sales 2015-2026
2.2 Global Tuberculosis Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tuberculosis Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tuberculosis Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tuberculosis Vaccines Competitor Landscape by Players
3.1 Tuberculosis Vaccines Sales by Manufacturers
3.1.1 Tuberculosis Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Tuberculosis Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Tuberculosis Vaccines Revenue by Manufacturers
3.2.1 Tuberculosis Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Vaccines Revenue in 2019
3.2.5 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tuberculosis Vaccines Price by Manufacturers
3.4 Tuberculosis Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccines Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Vaccines Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Vaccines Revenue by Type (2015-2020)
4.1.3 Tuberculosis Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccines Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Vaccines Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Vaccines Revenue by Application (2015-2020)
5.1.3 Tuberculosis Vaccines Price by Application (2015-2020)
5.2 Tuberculosis Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Vaccines by Country
6.1.1 North America Tuberculosis Vaccines Sales by Country
6.1.2 North America Tuberculosis Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tuberculosis Vaccines Market Facts & Figures by Type
6.3 North America Tuberculosis Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Tuberculosis Vaccines by Country
7.1.1 Europe Tuberculosis Vaccines Sales by Country
7.1.2 Europe Tuberculosis Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Vaccines Market Facts & Figures by Type
7.3 Europe Tuberculosis Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Vaccines by Region
8.1.1 Asia Pacific Tuberculosis Vaccines Sales by Region
8.1.2 Asia Pacific Tuberculosis Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tuberculosis Vaccines by Country
9.1.1 Latin America Tuberculosis Vaccines Sales by Country
9.1.2 Latin America Tuberculosis Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tuberculosis Vaccines Market Facts & Figures by Type
9.3 Central & South America Tuberculosis Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Vaccines by Country
10.1.1 Middle East and Africa Tuberculosis Vaccines Sales by Country
10.1.2 Middle East and Africa Tuberculosis Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Tuberculosis Vaccines Products Offered
11.1.5 Sanofi Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Tuberculosis Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Corporation Information
11.3.2 Serum Institute of India Description and Business Overview
11.3.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
11.3.5 Serum Institute of India Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Japan BCG Lab
11.5.1 Japan BCG Lab Corporation Information
11.5.2 Japan BCG Lab Description and Business Overview
11.5.3 Japan BCG Lab Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
11.5.5 Japan BCG Lab Related Developments
11.6 IDT Biologics
11.6.1 IDT Biologics Corporation Information
11.6.2 IDT Biologics Description and Business Overview
11.6.3 IDT Biologics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
11.6.5 IDT Biologics Related Developments
11.7 GreenSignal Bio Pharma
11.7.1 GreenSignal Bio Pharma Corporation Information
11.7.2 GreenSignal Bio Pharma Description and Business Overview
11.7.3 GreenSignal Bio Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
11.7.5 GreenSignal Bio Pharma Related Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Description and Business Overview
11.8.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
11.8.5 Taj Pharmaceuticals Related Developments
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Corporation Information
11.9.2 Bavarian Nordic Description and Business Overview
11.9.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
11.9.5 Bavarian Nordic Related Developments
11.10 China National Biotec Group
11.10.1 China National Biotec Group Corporation Information
11.10.2 China National Biotec Group Description and Business Overview
11.10.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
11.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
11.10.5 China National Biotec Group Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Tuberculosis Vaccines Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tuberculosis Vaccines Market Estimates and Projections by Region
12.1.1 Global Tuberculosis Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Tuberculosis Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tuberculosis Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tuberculosis Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tuberculosis Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tuberculosis Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tuberculosis Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Tuberculosis Vaccines Market Segments
Table 2. Ranking of Global Top Tuberculosis Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Immunotherapeutic Vaccines
Table 5. Major Manufacturers of Booster Vaccines
Table 6. Major Manufacturers of Others
Table 7. Global Tuberculosis Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Tuberculosis Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Tuberculosis Vaccines Sales by Regions 2015-2020 (K Doses)
Table 10. Global Tuberculosis Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Tuberculosis Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Tuberculosis Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Tuberculosis Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccines as of 2019)
Table 16. Tuberculosis Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Tuberculosis Vaccines Price (2015-2020) (USD/Dose)
Table 19. Tuberculosis Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Tuberculosis Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Tuberculosis Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 24. Global Tuberculosis Vaccines Sales Share by Type (2015-2020)
Table 25. Global Tuberculosis Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Tuberculosis Vaccines Revenue Share by Type (2015-2020)
Table 27. Tuberculosis Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 29. Global Tuberculosis Vaccines Sales Share by Application (2015-2020)
Table 30. North America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 31. North America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 35. North America Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 37. North America Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 39. Europe Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 43. Europe Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 45. Europe Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Tuberculosis Vaccines Sales by Region (2015-2020) (K Doses)
Table 47. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Tuberculosis Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 51. Asia Pacific Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 53. Asia Pacific Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 55. Latin America Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 59. Latin America Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 61. Latin America Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Tuberculosis Vaccines Sales by Country (2015-2020) (K Doses)
Table 63. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 67. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 69. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Major Businesses
Table 72. Sanofi Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. Sanofi Product
Table 74. Sanofi Recent Development
Table 75. Merck Corporation Information
Table 76. Merck Description and Major Businesses
Table 77. Merck Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Merck Product
Table 79. Merck Recent Development
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Major Businesses
Table 82. Serum Institute of India Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Serum Institute of India Product
Table 84. Serum Institute of India Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Major Businesses
Table 87. GlaxoSmithKline Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Japan BCG Lab Corporation Information
Table 91. Japan BCG Lab Description and Major Businesses
Table 92. Japan BCG Lab Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Japan BCG Lab Product
Table 94. Japan BCG Lab Recent Development
Table 95. IDT Biologics Corporation Information
Table 96. IDT Biologics Description and Major Businesses
Table 97. IDT Biologics Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. IDT Biologics Product
Table 99. IDT Biologics Recent Development
Table 100. GreenSignal Bio Pharma Corporation Information
Table 101. GreenSignal Bio Pharma Description and Major Businesses
Table 102. GreenSignal Bio Pharma Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. GreenSignal Bio Pharma Product
Table 104. GreenSignal Bio Pharma Recent Development
Table 105. Taj Pharmaceuticals Corporation Information
Table 106. Taj Pharmaceuticals Description and Major Businesses
Table 107. Taj Pharmaceuticals Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Taj Pharmaceuticals Product
Table 109. Taj Pharmaceuticals Recent Development
Table 110. Bavarian Nordic Corporation Information
Table 111. Bavarian Nordic Description and Major Businesses
Table 112. Bavarian Nordic Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Bavarian Nordic Product
Table 114. Bavarian Nordic Recent Development
Table 115. China National Biotec Group Corporation Information
Table 116. China National Biotec Group Description and Major Businesses
Table 117. China National Biotec Group Tuberculosis Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. China National Biotec Group Product
Table 119. China National Biotec Group Recent Development
Table 120. Global Tuberculosis Vaccines Sales Forecast by Regions (2021-2026) (K Doses)
Table 121. Global Tuberculosis Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Tuberculosis Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Tuberculosis Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 125. North America: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 127. Europe: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Tuberculosis Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 129. Asia Pacific: Tuberculosis Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 131. Latin America: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Tuberculosis Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 133. Middle East and Africa: Tuberculosis Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Tuberculosis Vaccines Players
Table 138. Tuberculosis Vaccines Customers List
Table 139. Tuberculosis Vaccines Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Immunotherapeutic Vaccines Product Picture
Figure 4. Booster Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tuberculosis Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Tuberculosis Vaccines Report Years Considered
Figure 11. Global Tuberculosis Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Tuberculosis Vaccines Sales 2015-2026 (K Doses)
Figure 13. Global Tuberculosis Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Tuberculosis Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 16. Global Tuberculosis Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Tuberculosis Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Vaccines Revenue in 2019
Figure 20. Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Tuberculosis Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Tuberculosis Vaccines Sales Market Share by Type in 2019
Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Tuberculosis Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Tuberculosis Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Tuberculosis Vaccines Sales Market Share by Application in 2019
Figure 28. Global Tuberculosis Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Tuberculosis Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 33. North America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Tuberculosis Vaccines Market Share by Type in 2019
Figure 39. North America Tuberculosis Vaccines Market Share by Application in 2019
Figure 40. Europe Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Tuberculosis Vaccines Market Share by Type in 2019
Figure 55. Europe Tuberculosis Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Tuberculosis Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Region in 2019
Figure 60. China Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Tuberculosis Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Tuberculosis Vaccines Market Share by Application in 2019
Figure 84. Latin America Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Tuberculosis Vaccines Market Share by Type in 2019
Figure 95. Latin America Tuberculosis Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Tuberculosis Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Tuberculosis Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Tuberculosis Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Tuberculosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Tuberculosis Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Tuberculosis Vaccines Market Share by Application in 2019
Figure 108. North America Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. North America Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Europe Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Asia Pacific Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Latin America Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Tuberculosis Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Middle East and Africa Tuberculosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs